(Q54469914)

30 May 2018

title

Defining a prognostic molecular profile for ductal adenocarcinoma of the pancreas highlights known key signaling pathways. (English)

1 reference

30 May 2018

invasive ductal carcinoma

0 references

1 reference

1 reference

3

1 reference

30 May 2018

author name string

Adam E Frampton

1

1 reference

30 May 2018

Jonathan Krell

2

1 reference

30 May 2018

Daniel Krell

4

1 reference

30 May 2018

Justin Stebbing

5

1 reference

30 May 2018

Leandro Castellano

6

1 reference

30 May 2018

Long R Jiao

7

1 reference

30 May 2018

publication date

1 October 2012

1 reference

30 May 2018

Expert Review of Anticancer Therapy

published in

1 reference

30 May 2018

volume

12

1 reference

30 May 2018

issue

10

1 reference

30 May 2018

page(s)

1275-1278

1 reference

30 May 2018

Integrative survival-based molecular profiling of human pancreatic cancer

cites work

1 reference

https://api.crossref.org/works/10.1586%2FERA.12.108

Semi-supervised methods to predict patient survival from gene expression data

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.12.108

A comprehensive analysis of common copy-number variations in the human genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.12.108

Integration of DNA copy number alterations and transcriptional expression analysis in human gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.12.108

Core signaling pathways in human pancreatic cancers revealed by global genomic analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.12.108

Genetic evolution of pancreatic cancer: lessons learnt from the pancreatic cancer genome sequencing project

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.12.108

Differential mechanisms of constitutive Akt/PKB activation and its influence on gene expression in pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.12.108

Incidence, mechanism and prognostic value of activated AKT in pancreas cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.12.108

PTEN is a major tumor suppressor in pancreatic ductal adenocarcinoma and regulates an NF-κB-cytokine network

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.12.108

Correlation of basal EGFR expression with pancreatic cancer grading but not with clinical outcome after gemcitabine-based treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.12.108

Src-catalyzed phosphorylation of c-Cbl leads to the interdependent ubiquitination of both proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.12.108

Cbl-b-dependent coordinated degradation of the epidermal growth factor receptor signaling complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.12.108

In hepatocellular carcinoma miR-519d is up-regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.12.108

Integrated analysis of miRNA and mRNA profiles enables target acquisition in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.12.108

MicroRNA Molecular Profiles Associated with Diagnosis, Clinicopathologic Criteria, and Overall Survival in Patients with Resectable Pancreatic Ductal Adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.12.108

21 January 2018

Identifiers

DOI

10.1586/ERA.12.108

1 reference

30 May 2018

1 reference

30 May 2018